Wave Life Sciences Ltd (WVE)

Jun 14, 2026

Wave Life Sciences Ltd. (WVE) stock price, news, quote and history - Yahoo Finance UK

Jun 14, 2026

Jun 13, 2026

Is Wave Life Sciences Ltd. (WVE) A Good Stock To Buy Now? - Insider Monkey

Jun 13, 2026

Jun 13, 2026

What Went Wrong For WVE? The Obesity Drug Trial Data That Spooked Investors - Stocktwits

Jun 13, 2026

Jun 13, 2026

ARWR Stock Slid Lower Today — What Does Wave Life Sciences Have To Do With It? - Stocktwits

Jun 13, 2026

Jun 12, 2026

WVE News | WAVE LIFE SCIENCES LTD (NASDAQ:WVE) - ChartMill

Jun 12, 2026

Jun 12, 2026

Failed Obesity Trial And Investor Exit Might Change The Case For Investing In Wave Life Sciences (WVE) - Sahm

Jun 12, 2026

Jun 11, 2026

Inside Wells Fargo’s Take on Wave Life Sciences Ltd (WVE) Stock - Insider Monkey

Jun 11, 2026

Jun 11, 2026

H.C. Wainwright Maintains Wave Life Sciences(WVE.US) With Buy Rating, Maintains Target Price $13 - Moomoo

Jun 11, 2026

Jun 10, 2026

Billionaire Lee Ainslie’s 5 Stocks with Huge Upside Potential - Insider Monkey

Jun 10, 2026

Jun 09, 2026

WVE Stock Price, Quote & Chart - ChartMill

Jun 09, 2026

Jun 08, 2026

(WVE) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily

Jun 08, 2026

Jun 08, 2026

Transcript : Wave Life Sciences Ltd. Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026, Jun-08-2026 08 - marketscreener.com

Jun 08, 2026

Jun 08, 2026

WVE: WVE-007 advances to phase II-A for obesity, with RNA editing programs nearing key milestones - TradingView

Jun 08, 2026

Jun 08, 2026

Wave Life Sciences (WVE) Valuation After Obesity Drug Setback And Institutional Investor Exit - simplywall.st

Jun 08, 2026

Jun 06, 2026

Wave Life Sciences Faces Setback As WVE-007 Fails And Investor Exits - simplywall.st

Jun 06, 2026

Jun 05, 2026

WAVE LIFE SCIENCES LTD (WVE) Stock Chart - ChartMill

Jun 05, 2026

Jun 03, 2026

Wave Life Sciences Hits Day Low at $5.65 Amid Price Pressure - MarketsMojo

Jun 03, 2026

Jun 01, 2026

Wave Life Sciences to Present at Upcoming Investor Conferences - The Manila Times

Jun 01, 2026

Jun 01, 2026

This $5.5 Million Exit Raises Questions After Wave Life Sciences' Rough First Quarter - AOL.com

Jun 01, 2026

May 31, 2026

Is RNA Editor WVE-006’s MZ-Like AAT Restoration Altering The Investment Case For Wave Life Sciences (WVE)? - simplywall.st

May 31, 2026

May 29, 2026

Wave Life Science prices upsized $350M stock ofeering - MSN

May 29, 2026

May 29, 2026

Wells Fargo Maintains Wave Life Sciences (WVE) Overweight Recommendation - MSN

May 29, 2026

May 28, 2026

(WVE) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily

May 28, 2026

May 28, 2026

EDGAR Filing Documents for 0001193125-25-044876 - SEC.gov

May 28, 2026

May 27, 2026

Wedbush Maintains Wave Life Sciences(WVE.US) With Buy Rating, Maintains Target Price $15 - Moomoo

May 27, 2026

May 27, 2026

Investigation launched into Wave Life Sciences over possible securities law violations after stock drop - Pluang

May 27, 2026

May 27, 2026

Wave Life Sciences Ltd. Shareholders Are Encouraged to - GlobeNewswire

May 27, 2026

May 26, 2026

Wave Life Sciences(WVE) Stock Options Chain | Quotes & News - Moomoo

May 26, 2026

May 25, 2026

Should WVE-006’s RNA-Editing AAT Data Shift the Risk-Reward Calculus for Wave Life Sciences (WVE) Investors? - Yahoo Finance

May 25, 2026

May 23, 2026

Wave Life Sciences (WVE) Valuation Check After Sharp Share Price Weakness - simplywall.st

May 23, 2026

May 22, 2026

WAVE Life Sciences Analyst Ratings and Price Targets | NASDAQ:WVE - Benzinga

May 22, 2026

May 21, 2026

Wells Fargo Maintains Wave Life Sciences(WVE.US) With Buy Rating, Maintains Target Price $14 - Moomoo

May 21, 2026

May 21, 2026

Wave Life Sciences (WVE) Is Down 11.4% After Positive WVE-006 AATD Data and Accelerated Path Update - simplywall.st

May 21, 2026

May 20, 2026

Wave Life Sciences: 'Strong Buy' On DMD NDA Filing WVE-N531 And Released AATD Data - Seeking Alpha

May 20, 2026

May 20, 2026

WVE Maintained by Wells Fargo -- Price Target Raised to $14.00 - GuruFocus

May 20, 2026

May 20, 2026

Wave Life Sciences Is Maintained at Overweight by Wells Fargo - Moomoo

May 20, 2026

May 20, 2026

CCORF Maintains Wave Life Sciences(WVE.US) With Buy Rating, Maintains Target Price $43 - Moomoo

May 20, 2026

May 20, 2026

WVE: Advancing siRNA and RNA editing therapies with strong clinical data and regulatory momentum - TradingView

May 20, 2026

May 20, 2026

Wells Fargo raises Wave Life Sciences price target on AATD data - Investing.com Australia

May 20, 2026

May 20, 2026

Wells Fargo Maintains Wave Life Sciences(WVE.US) With Buy Rating, Cuts Target Price to $14 - Moomoo

May 20, 2026

May 20, 2026

Wave Life Sciences Signals Momentum in Earnings Call - TipRanks

May 20, 2026

May 19, 2026

Wave Life Sciences crashes deep into oversold territory as obesity drug data disappoints. Should you buy the dip? - MSN

May 19, 2026

May 19, 2026

WVE Maintained by HC Wainwright & Co. -- Price Target Lowered to $13 - GuruFocus

May 19, 2026

May 19, 2026

Wave Life Sciences' New Data From AATD Study Met Expectations, Wedbush Says - Moomoo

May 19, 2026

May 19, 2026

Cantor Fitzgerald reiterates Overweight on Wave Life Sciences stock By Investing.com - Investing.com South Africa

May 19, 2026

May 19, 2026

Wave Life Sciences Supports AlphaDetect to Accelerate Detection of Alpha-1 - PR Newswire

May 19, 2026